Meng Cheng

Jiangxi University of Traditional Chinese Medicine

H指数:23

被引数:1,971

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeted nanoemulsion Blocks MTFR2-HIF-1α-EZH2/FoxM1 axis to suppress tongue squamous cell carcinoma invasion and metastasis

靶向纳米乳液阻断MTFR2-HIF-1α-EZH2/FoxM1轴以抑制舌鳞状细胞癌的侵袭和转移

Phytomedicine

IF8.3

2026-05-230

OAAI

Enhanced Nutritional Support May Ameliorate Rivaroxaban-Related Rapid Renal Function Decline: New Insights from a Real-World Study

增强营养支持可能改善利伐沙班相关快速肾功能下降：真实世界研究的新见解

Drug Design; Development and Therapy

IF0

2025-12-030

OAAI

Direct Oral anticoagulants in pulmonary thromboembolism therapy: the generalization-individualization dilemma and the path to risk stratification—a perspective

直接口服抗凝剂在肺血栓栓塞症治疗中的应用：普遍化与个体化的两难困境及风险分层之路——观点

Frontiers in Medicine

IF3

2025-12-010

OAAI

U-shaped association of body roundness index with all-cause and cardiovascular mortality in individuals with chronic kidney disease

体圆度指数与慢性肾脏病患者全因死亡和心血管死亡率之间的U型关联

Renal Failure

IF3

2025-09-090

OAAI

Intestinal transporters and oral absorption enhancing strategies based on these transporters

肠道转运蛋白及基于这些转运蛋白的口服吸收增强策略

CHINESE CHEMICAL LETTERS

IF8.9

2025-05-010

PRE

Nanomaterial-based approaches to neurotoxin neutralization in neurodegenerative diseases

基于纳米材料的方法在神经退行性疾病中神经毒素的中和

NANOMEDICINE

IF3.9

2025-04-030

PRE

Phenylethyl isothiocyanate mitigates drug-induced liver injury in mice by inhibiting hepatocyte pyroptosis through the NLRP3-caspase-1-GSDMD pathway

苯乙异硫氰酸酯通过抑制NLRP3-caspase-1-GSDMD通路介导的肝细胞焦亡，减轻小鼠药物诱导的肝损伤。

FRONTIERS IN PHARMACOLOGY

IF4.8

2025-03-250

A Label Free Fluorescent Aptamer Sensor Based on the Combined Action of Graphene Oxide and SYBR Green I for the Detection of Aflatoxin B1

IEEE TRANSACTIONS ON NANOBIOSCIENCE

IF4.4

2025-01-011

PRE

Model Testing and Numerical Simulation of the Bearing Characteristics of Screw-Core Cement Mixing Pile

BUILDINGS

IF3.1

2024-12-260

Study on the preparation of stabilizer-free silymarin nanocrystals and its oral absorption mechanisms

international journal of pharmaceutics

IF6.4

2024-12-011

OAAI

Simultaneous detection of multiple urinary biomarkers in patients with early-stage diabetic kidney disease using Luminex liquid suspension chip technology

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2024-08-200

OAAI

Macromolecular Nano-Assemblies for Enhancing the Effect of Oxygen-Dependent Photodynamic Therapy Against Hypoxic Tumors

CHEMISTRY-A EUROPEAN JOURNAL

IF3.7

2024-07-110

PRE

Female-sensitive multifunctional phytoestrogen nanotherapeutics for tailored management of postmenopausal Alzheimer's disease

NANO TODAY

IF10.9

2024-02-012

PRE

Development and analysis of a universal label-free micro/nano component for three-channel detection of silver ions, mercury ions, and tetracycline

ANALYTICA CHIMICA ACTA

IF6

2023-10-010

PRE

mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer's Disease Management

ACS NANO

IF16

2023-08-1113

PRE

Chain hybridization-based CRISPR-lateral flow assay enables accurate gene visual detection

基于链杂交的CRISPR侧流分析可实现准确的基因视觉检测

ANALYTICA CHIMICA ACTA

IF6

2023-08-0114

PRE

Research Progress on the Mechanism of Nanoparticles Crossing the Intestinal Epithelial Cell Membrane

PHARMACEUTICS

IF5.5

2023-06-2514

OAAI

A comprehensive analysis of single-cell RNA transcriptome reveals unique SPP1+chondrocytes in human osteoarthritis

COMPUTERS IN BIOLOGY AND MEDICINE

IF6.3

2023-06-019

OAAI

Carrier-free quercetin nanomedicine blocks NLRP3 deubiquitination and TXNIP recruitment for Parkinson?s disease therapy

CHEMICAL ENGINEERING JOURNAL

IF13.2

2023-05-015

PRE

Clinical use of HD-MTX monotherapy in a rare case of refractory primary bone diffuse large B-cell lymphoma with long-term survival after local radiotherapy: A case report

FRONTIERS IN MEDICINE

IF3

2022-12-210

OAAI

Meng Cheng

个人简介

教育背景

工作经历

荣誉奖项

研究方向